Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population - ECHO

Study identifier:D9612R00010

ClinicalTrials.gov identifier:NCT03118778

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population: A Descriptive Retrospective Observational Study using Database

Medical condition

Gastrointestinal disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

90895

Study type

Observational

Age

N/A

Date

Study Start Date: 28 Apr 2017
Primary Completion Date: 10 Jul 2017
Study Completion Date: 10 Jul 2017

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -

Verification:

Verified 01 Jun 2018 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria